Integration of blood‐based biomarkers and genomic variants identifies individuals with mild cognitive impairment who benefit from multidomain intervention
The findings suggest that BBMs, potentially in combination with genetic information, may help identify individuals with a more progressive AD‐related biological profile who may derive greater benefit from multidomain intervention.
Tetsuaki Kimura, A. Nakamura, T. Sugimoto et al.
· Alzheimer's & Dementia · 0 citations